Concepedia

Rosie Jaramillo

RJ

Statistics

Publications

9

Citations

417

H-Index

9

Active since

2017

Affiliations

South Texas Veterans Health Care System(Current)

The University of Texas Health Science Center at San Antonio

Viamet Pharmaceuticals (United States)

National Institutes of Health

National Center for Advancing Translational Sciences

Rosie Jaramillo is an author at South Texas Veterans Health Care System.

Publications per year

2017–2019

9

Publications

9

The Fungal Cyp51-Specific Inhibitor VT-1598 Demonstrates <i>In Vitro</i> and <i>In Vivo</i> Activity against Candida auris

Nathan P. Wiederhold, Shawn R. Lockhart, Laura K. Najvar et al. · Antimicrobial Agents and Chemotherapy · 2018 · 74 citations · Full text

The Orotomide Olorofim Is Efficacious in an Experimental Model of Central Nervous System Coccidioidomycosis

Nathan P. Wiederhold, Laura K. Najvar, Rosie Jaramillo et al. · Antimicrobial Agents and Chemotherapy · 2018 · 72 citations · Full text

Efficacy of Delayed Therapy with Fosmanogepix (APX001) in a Murine Model of Candida auris Invasive Candidiasis

Nathan P. Wiederhold, Laura K. Najvar, Karen Joy Shaw et al. · Antimicrobial Agents and Chemotherapy · 2019 · 63 citations · Full text

The Novel Fungal Cyp51 Inhibitor VT-1598 Is Efficacious in Experimental Models of Central Nervous System Coccidioidomycosis Caused by Coccidioides posadasii and Coccidioides immitis

Nathan P. Wiederhold, Lisa F. Shubitz, Laura K. Najvar et al. · Antimicrobial Agents and Chemotherapy · 2018 · 49 citations · Full text

The Novel Arylamidine T-2307 Demonstrates <i>In Vitro</i> and <i>In Vivo</i> Activity against Candida auris

Nathan P. Wiederhold, Laura K. Najvar, Rosie Jaramillo et al. · Antimicrobial Agents and Chemotherapy · 2019 · 44 citations · Full text

1–5 of 9